BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37699362)

  • 21. Time-varying prognostic value of primary tumor sidedness in metastatic colorectal cancer: A population-based study and meta-analysis.
    van der Kruijssen DEW; van der Kuil AJS; Vink GR; Punt CJA; de Wilt JHW; Elias SG; Koopman M
    Int J Cancer; 2023 Apr; 152(7):1360-1369. PubMed ID: 36346099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers.
    Cercek A; Chatila WK; Yaeger R; Walch H; Fernandes GDS; Krishnan A; Palmaira L; Maio A; Kemel Y; Srinivasan P; Bandlamudi C; Salo-Mullen E; Tejada PR; Belanfanti K; Galle J; Joseph V; Segal N; Varghese A; Reidy-Lagunes D; Shia J; Vakiani E; Mondaca S; Mendelsohn R; Lumish MA; Steinruecke F; Kemeny N; Connell L; Ganesh K; Markowitz A; Nash G; Guillem J; Smith JJ; Paty PB; Zhang L; Mandelker D; Birsoy O; Robson M; Offit K; Taylor B; Berger M; Solit D; Weiser M; Saltz LB; Aguilar JG; Schultz N; Diaz LA; Stadler ZK
    J Natl Cancer Inst; 2021 Nov; 113(12):1683-1692. PubMed ID: 34405229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Predictive Role of Primary Tumour Sidedness in Metastatic Colorectal Cancer Treated With Targeted Agents.
    Fiala O; Ostasov P; Hosek P; Sorejs O; Liska V; Buchler T; Poprach A; Kucera R; Topolcan O; Sustr J; Sedivcova M; Finek J
    Anticancer Res; 2019 Oct; 39(10):5645-5652. PubMed ID: 31570462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Palliative resection of the primary tumor is associated with improved overall survival in incurable stage IV colorectal cancer: A nationwide population-based propensity-score adjusted study in the Netherlands.
    't Lam-Boer J; Van der Geest LG; Verhoef C; Elferink ME; Koopman M; de Wilt JH
    Int J Cancer; 2016 Nov; 139(9):2082-94. PubMed ID: 27342618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Age With Treatment-Related Adverse Events and Survival in Patients With Metastatic Colorectal Cancer.
    Meng L; Thapa R; Delgado MG; Gomez MF; Ji R; Knepper TC; Hubbard JM; Wang X; Permuth JB; Kim RD; Laber DA; Xie H
    JAMA Netw Open; 2023 Jun; 6(6):e2320035. PubMed ID: 37358854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metastatic Colorectal Cancer in Young Adults: A Study From the South Australian Population-Based Registry.
    Vatandoust S; Price TJ; Ullah S; Roy AC; Beeke C; Young JP; Townsend A; Padbury R; Roder D; Karapetis CS
    Clin Colorectal Cancer; 2016 Mar; 15(1):32-6. PubMed ID: 26341410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival Benefit of Palliative Primary Tumor Resection Based on Tumor Location in Patients with Metastatic Colorectal Cancer: A Single-center Retrospective Study.
    Kim JH; Jin S; Jeon MJ; Jung HY; Byun S; Jung K; Kim SE; Moon W; Park MI; Park SJ
    Korean J Gastroenterol; 2020 Jul; 76(1):17-27. PubMed ID: 32703916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benefit of primary tumor resection in stage IV colorectal cancer with unresectable metastasis: a multicenter retrospective study using a propensity score analysis.
    Ishihara S; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Hata K; Nozawa H; Kazama S; Yamaguchi H; Sunami E; Kitayama J; Sugihara K; Watanabe T
    Int J Colorectal Dis; 2015 Jun; 30(6):807-12. PubMed ID: 25922146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracapsular lymph node involvement is associated with colorectal liver metastases and impact outcome after hepatectomy for colorectal metastases.
    Suzuki H; Fujii T; Asao T; Tsutsumi S; Wada S; Araki K; Kubo N; Watanabe A; Tsukagoshi M; Kuwano H
    World J Surg; 2014 Aug; 38(8):2079-88. PubMed ID: 24615606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction models for overall and cancer-specific survival in patients with metastatic early-onset colorectal cancer: a population-based study.
    Xu C; Zhang F; Cheng W; Zhu Y
    Int J Colorectal Dis; 2023 Apr; 38(1):99. PubMed ID: 37067609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conversion to Resection in Patients Receiving Systemic Chemotherapy for Unresectable and/or Metastatic Colorectal Cancer-Predictive Factors and Prognosis.
    Nozawa H; Ishihara S; Kawai K; Hata K; Kiyomatsu T; Tanaka T; Nishikawa T; Otani K; Yasuda K; Sasaki K; Kaneko M; Murono K
    Clin Colorectal Cancer; 2018 Mar; 17(1):e91-e97. PubMed ID: 29113730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival of Patients with Deficient Mismatch Repair Versus Proficient Mismatch Repair Metastatic Colorectal Cancer Receiving Curative-Intent Local Treatment of Metastases in a Nationwide Cohort.
    Zwart K; van der Baan FH; Punt CJA; Wensink GE; Bolhuis K; Laclé MM; van Grevenstein WMU; Hagendoorn J; de Hingh IH; Koopman M; Vink G; Roodhart J
    Ann Surg Oncol; 2023 Oct; 30(11):6762-6770. PubMed ID: 37528303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real-world first-line treatment of patients with BRAF
    Martinelli E; Cremolini C; Mazard T; Vidal J; Virchow I; Tougeron D; Cuyle PJ; Chibaudel B; Kim S; Ghanem I; Asselain B; Castagné C; Zkik A; Khan S; Arnold D
    ESMO Open; 2022 Dec; 7(6):100603. PubMed ID: 36368253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognosis of Ulcerative Colitis-Associated Colorectal Carcinoma Compared to Sporadic Colorectal Carcinoma: A Matched Pair Analysis.
    Leowardi C; Schneider ML; Hinz U; Harnoss JM; Tarantino I; Lasitschka F; Ulrich A; Büchler MW; Kadmon M
    Ann Surg Oncol; 2016 Mar; 23(3):870-6. PubMed ID: 26467453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of disease-free interval in colorectal cancer: Is it time?
    Birgin E; Doyon F; Burkert J; Téoule P; Rasbach E; Rahbari M; Reissfelder C; Betzler A; Rahbari NN
    Eur J Surg Oncol; 2022 Sep; 48(9):2032-2038. PubMed ID: 35738980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic impact and survival outcomes of colon perforation in patients with metastatic colorectal cancer: a multicenter retrospective cohort study.
    Nakao E; Kawamura H; Honda M; Takano Y; Kinuta S; Kamiga T; Yamazaki S; Muto A; Shiraso S; Yamashita N; Iwao T; Kono K; Konno S
    Int J Clin Oncol; 2024 Feb; 29(2):179-187. PubMed ID: 38078975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-Term and Oncologic Outcomes of Robotic Versus Laparoscopic Liver Resection for Metastatic Colorectal Cancer: A Multicenter, Propensity Score Matching Analysis.
    Beard RE; Khan S; Troisi RI; Montalti R; Vanlander A; Fong Y; Kingham TP; Boerner T; Berber E; Kahramangil B; Buell JF; Martinie JB; Vrochides D; Shen C; Molinari M; Geller DA; Tsung A
    World J Surg; 2020 Mar; 44(3):887-895. PubMed ID: 31748885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathological characteristics and prognosis analysis of ovarian metastases in colorectal cancer: a single-center experience.
    Zhou R; Liu Y; Wang Y; Huo X; Zhu J; Zhang T
    Int J Clin Oncol; 2020 Oct; 25(10):1822-1829. PubMed ID: 32591962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metastatic colorectal cancer prior to expanded RAS assessment: evidence from long-term outcome analysis of a real-life cohort within a dedicated colorectal cancer unit.
    Bertero L; Spadi R; Osella-Abate S; Mariani S; Castellano I; Gambella A; Racca P; Morino M; Cassoni P
    World J Surg Oncol; 2020 Apr; 18(1):65. PubMed ID: 32241284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative study of laparoscopic versus open technique for simultaneous resection of colorectal cancer and liver metastases with propensity score analysis.
    Shin JK; Kim HC; Lee WY; Yun SH; Cho YB; Huh JW; Park YA; Heo JS; Kim JM
    Surg Endosc; 2020 Nov; 34(11):4772-4780. PubMed ID: 31732856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.